FDA study: DNA contamination found in Pfizer vaccines


The following information is from Children’s Health Defense.


A peer-reviewed study conducted at an FDA laboratory has revealed alarming levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccines. The groundbreaking research, published on December 29, 2024, in the Journal of High School Science, found contamination levels 6 to 470 times higher than regulatory safety limits.

The study, performed by three high school students under the supervision of FDA scientists, tested two vaccine lots and uncovered residual DNA levels exceeding 10 nanograms per dose — far above safety thresholds. While the health risks posed by small DNA fragments remain uncertain, the study warned of potential insertional mutagenesis, where foreign DNA may integrate into the human genome, potentially disrupting genes or increasing cancer risk.

“DNA in vaccines can pose health risks because the DNA could integrate into the genome and cause disruption of the genome … or it could disrupt other genes that are related to cancer.”
Kevin McKernan, Founder, Medicinal Genomics

The findings have reignited debates about vaccine safety, with some experts calling for immediate recalls. Nikolai Petrovsky, Ph.D., director of biotechnology firm Vaxine Pty Ltd., described the results as a “smoking gun” that exposes unacceptable risks. Investigative medical reporter Maryanne Demasi, Ph.D., pointed out that regulators previously dismissed contamination concerns as “baseless.”

Independent labs in the USCanada, Australia, Germany and France have reported similar findings, adding weight to the FDA lab’s study. Despite this growing evidence, the FDA has not issued public warnings or initiated recalls.

“It is ironic that it takes student researchers at the FDA to do the work of the FDA regulators. Where is the FDA now? Why hasn’t the public been alerted of this?”
— Brian Hooker, Ph.D., Children’s Health Defense

The study has intensified scrutiny on vaccine manufacturing practices and regulatory oversight, placing both Pfizer and health regulators under pressure. Experts have urged immediate action to address the risks posed by DNA contamination.

For more details, read the full article here.


Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top